Modifications of hormone excretion patterns after treatment with 6alpha-methyl-17alpha-acetoxyprogesterone and 17alpha-ethynyl-estradiol.
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000652:urine*; D003864:Depression, Chemical; D004958:Estradiol / Q000652:urine; D004964:Estriol / Q000652:urine; D004967:Estrogens / Q000652:urine*; D004970:Estrone / Q000652:urine; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000652:urine; D006801:Humans; D007986:Luteinizing Hormone / Q000652:urine; D008525:Medroxyprogesterone / Q000494:pharmacology*; D011276:Pregnanediol / Q000652:urine; D011279:Pregnanetriol / Q000652:urine; D011372:Progestins / Q000652:urine*
D004967:Estrogens; D011372:Progestins; D011279:Pregnanetriol; D004970:Estrone; D004997:Ethinyl Estradiol; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D004964:Estriol; D008525:Medroxyprogesterone; D011276:Pregnanediol